Accendra Health Inc
Investor relations
Report Dates
Investor relations overview for Accendra Health Inc (ACH): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/29/2026.
EPS estimate beaten
Earnings Call Transcripts
- 08/10/2026 Earnings Call Q2 2026 Open →
- 05/11/2026 Earnings Call Q1 2026 Open →
- 02/19/2026 Earnings Call Q4 2025 Open →
- 10/30/2025 Earnings Call Q3 2025 Open →
- 08/11/2025 Earnings Call Q2 2025 Open →
- 05/08/2025 Earnings Call Q1 2025 Open →
- 02/28/2025 Earnings Call Q4 2024 Open →
- 11/04/2024 Earnings Call Q3 2024 Open →
- 08/02/2024 Earnings Call Q2 2024 Open →
- 05/03/2024 Earnings Call Q1 2024 Open →
News on This Stock
- 09/17/2026 ACCENDRA HEALTH INC/VA/ (ACH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
- 08/17/2026 ACCENDRA HEALTH INC/VA/ (ACH): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
- 08/10/2026 ACCENDRA HEALTH INC/VA/ (ACH): Entry into a Material Definitive Agreement; Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
- 08/10/2026 ACCENDRA HEALTH INC/VA/ (ACH): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
- 08/10/2026 ACCENDRA HEALTH INC/VA/ (ACH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
Automatically matched wire and portal stories; external links open the original source.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.